Cernum Biosciences Peptide Store Recognized in Independent Review for Transparency and Quality

Cernum Biosciences has been recognized in a 2026 independent review for its quality standards, transparency, and ...
Seeking Alpha

Neurocrine Biosciences Announces Publication of Landmark Narrative Review on FDA-Approved VMAT2 Inhibitors Demonstrating Unique Profile of INGREZZA® (valbenazine) Capsules

SAN DIEGO, Nov. 20, 2025 /PRNewswire/ -- Neurocrine Biosciences, Inc. (NBIX) (Nasdaq: NBIX) today announced the publication of a comprehensive peer-reviewed narrative review that consolidates ...
Seeking Alpha

Neurocrine Biosciences Announces U.S. FDA Accepts New Drug Applications and Grants Priority Review for Crinecerfont for Pediatric and Adult Patients with CAH

PDUFA Target Action Dates in Late December 2024 Highly Selective CRF 1 Antagonist is the Potential First New Treatment for CAH in 70 Years SAN DIEGO, July 1, 2024 /PRNewswire/ -- Neurocrine ...